/

Electronics & Software

/

Epredia

Epredia

Epredia

Verified Nov 2026

Electronics & Software

·

United States flag

Portsmouth, New Hampshire

·

Since 2019

Epredia makes pre-analytical solutions for anatomical pathology and cancer diagnostics, including tissue processors, digital imaging scanners, microscope slides, and autopsy workflow tools. The company is headquartered in Portsmouth, New Hampshire, United States, and was founded in 2019. It has an estimated 1,000 to 5,000 employees and an estimated revenue band of $100 to $250 million, and it is privately held. Its customers include laboratories, hospitals, pathology centers, and research institutions. In May 2026, it launched the SlideMate thermal slide printer for on-demand slide printing and traceability.

Epredia

Verified Nov 2026

AT A GLANCE

Founded

2019

Headquarters

United States flag

Portsmouth, New Hampshire

Employees

1,000-5,000

Ownership

Epredia at a glance

Revenue

$100-250M

Est. band

Employees

1,000-5,000

Founded

2019

Headquarters

Portsmouth, New Hampshire

Certifications

ISO 13485 · ISO 9001

Import activity

6

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

Sourcing and import activity

From US customs bill-of-lading records

US sea imports

6

Named foreign suppliers

4

Top origins

China · Canada · United Kingdom · Belgium

Chart of the supplier's US import shipment volume trend over time

Shared foreign counterparties do not establish that these companies buy from Epredia.

What this tells a buyer

Epredia most recently launched automated archiving of pathology samples in July 2026, extending traceability across cancer diagnostics workflows.

Epredia lists glass products among its offerings and holds ISO 13485 and ISO 9001 certifications.

Epredia is a privately held company serving the healthcare and life sciences diagnostics market, and its revenue band is an estimate.

Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026

STABILITY SIGNALS

Established & active

7 years in operation (founded 2019).

Holds ISO 13485, ISO 9001 certification(s) per public sources.

Overview

Epredia makes pre-analytical solutions for anatomical pathology and cancer diagnostics, including tissue processors, digital imaging scanners, microscope slides, and autopsy workflow tools. The company is headquartered in Portsmouth, New Hampshire, United States, and was founded in 2019. It has an estimated 1,000 to 5,000 employees and an estimated revenue band of $100 to $250 million, and it is privately held. Its customers include laboratories, hospitals, pathology centers, and research institutions. In May 2026, it launched the SlideMate thermal slide printer for on-demand slide printing and traceability.

At a glance

Attribute

Detail

Founded

2019

Headquarters

Portsmouth, New Hampshire

Employees

1,000-5,000

Revenue

$100-250M (estimated)

Primary capability

Electronics & Software

Certifications

ISO 13485 · ISO 9001

What Epredia makes

Epredia lists glass products among its offerings and holds ISO 13485 and ISO 9001 certifications.

Products and capabilities described on the company's own site include Glass (source: epredia.com).

Certifications

Epredia is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:

Trade and customs footprint

Epredia most recently launched automated archiving of pathology samples in July 2026, extending traceability across cancer diagnostics workflows. US customs bill-of-lading records list 6 inbound shipments across 4 foreign suppliers, with top origins including China · Canada · United Kingdom · Belgium.

Latest developments

Company details

Epredia is a privately held company serving the healthcare and life sciences diagnostics market, and its revenue band is an estimate. Epredia was founded in 2019, has an estimated 1,000-5,000 employees, and is headquartered in Portsmouth, New Hampshire. On the LightSource stability read it is rated "Established & active": 7 years in operation (founded 2019). Holds ISO 13485, ISO 9001 certification(s) per public sources.

Frequently asked questions

What does Epredia make?

Epredia makes pre-analytical solutions for anatomical pathology and cancer diagnostics, including tissue processors, digital imaging scanners, microscope slides, and autopsy workflow tools. The company is headquartered in Portsmouth, New Hampshire, United States, and was founded in 2019. It has an estimated 1,000 to 5,000 employees and an estimated revenue band of $100 to $250 million, and it is privately held. Its customers include laboratories, hospitals, pathology centers, and research institutions. In May 2026, it launched the SlideMate thermal slide printer for on-demand slide printing and traceability.

Where is Epredia headquartered?

Epredia is headquartered in Portsmouth, New Hampshire (20 Post Rd, Portsmouth, New Hampshire, 03801-5622).

When was Epredia founded?

Epredia was founded in 2019.

How big is Epredia?

Epredia has an estimated 1,000-5,000 employees, with revenue in the $100-250M range (estimated).

What certifications does Epredia hold?

Epredia lists ISO 13485 · ISO 9001 on its website. Confirm the certified scope for the specific plant producing your part.

Does Epredia import from overseas suppliers?

US customs bill-of-lading records show 6 inbound shipments for Epredia, with top origins including China · Canada · United Kingdom · Belgium.

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Portsmouth, New Hampshire (HQ)Headquarters · United States
Portsmouth, New Hampshire (HQ)20 Post Rd, Portsmouth, New Hampshire, 03801-5622, United StatesHeadquarters

Certification

ISO 13485 · ISO 9001

Evaluating suppliers like these?

This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.